PubMed Health⌕ Search

Biomedical subjects

H J Van Schaik

Publications and source records attributed to H J Van Schaik.

5 recordsLinked to original sources

Autofluorescence of the diabetic and healthy human cornea in vivo at different excitation wavelengths.

Corneal autofluorescence is higher in diabetes mellitus patients with retinopathy than in healthy subjects. In this study, the excitation spectra of corneal autofluorescence of diabetic patients and healthy controls in the range 365 nm-480 nm were compared in an attempt to identify the fluorophores responsible for corneal autofluorescence in health and disease (diabetes). Spectral measurements (from one eye) were recorded from five patients with proliferative diabetic retinopathy and five age-matched healthy controls, using a modified commercial scanning fluorophotometer with a mercury arc or a tungsten halogen lamp as excitation light source in combination with interference filters (excitation wavelengths: 365, 405, 420, 430, 436, 440, 450, 470 and 480 nm; bandwidth: 10 nm). Fluorescence emission was measured in the range 532 nm-630 nm. The sensitivity of the modified fluorophotometer was calibrated by using the excitation spectrum of fluorescein as a reference. The corneal excitation efficiency of the diabetic patients was higher than that of the healthy controls at each wavelength investigated (Mann-Witney test P<0.0005). The ratio between the mean values of both groups was equal for each excitation wavelength (mean ratio 1.9+/-0.12s.d.,P>0. 2), suggesting that the excitation spectra were equal. This indicates that the same fluorophores are responsible for the corneal autofluorescence in both groups. The shapes of the excitation spectra suggest the involvement of flavins, NAD(P)H, and at least one other, as yet unidentified, fluorophore.

Adolescent↗

Autofluorescence distribution along the corneal axis in diabetic and healthy humans.

Corneal autofluorescence, as measured with a commercial scanning fluorophotometer (lambda(exc): 415-491 nm; lambda(em): 515-630 nm), is increased in patients with diabetes mellitus. However, such fluorophotometers register an average fluorescence signal over all corneal layers as a consequence of their limited axial resolution of 0.5 mm. In order to determine the location of the fluorophores responsible for the increased corneal autofluorescence measured in diabetics, an attempt was made to measure in vivo the distribution of autofluorescence along the optical axis of the cornea with a modified slitlamp. Fluorescence excitation and emission filters identical to those of the scanning fluorophotometer were fitted to a slitlamp equipped with a slow scan CCD camera. Corneal autofluorescence intensity profiles were obtained with the slitlamp in five patients with severe diabetic retinopathy and compared to those of age-matched healthy controls. Corneal autofluorescence was also measured with the scanning fluorophotometer for comparison. The resolution of the CCD camera for measurement of fluorescence along the corneal axis was 0.1 mm. The corneal autofluorescence intensity of the patients and the healthy controls gradually decreased by about the same amount from the endothelium to the epithelium (57% mm(-1)+/-6 s.d. and 52% mm(-1)+/-5 s.d., respectively). The area under the fluorescence intensity curve was significantly greater for the patients than for the healthy controls (factor 2.4+/-1.0 s.d., P<0.001) and was proportional to the corneal fluorescence measured with the scanning fluorophotometer (r=0.92, P<0.001). The results show that (1) the distribution of autofluorescence along the corneal axis can be measured in vivo in humans, (2) the fluorophores involved are distributed throughout the cornea, and (3) the relative distribution of fluorescence is similar in diabetic patients and healthy controls.

Cornea↗

Permeability of the blood-retinal barrier in healthy humans. European Concerted Action on Ocular Fluorometry.

BACKGROUND: The aim of this study was to compare the inward permeability of the blood-retinal barrier in healthy subjects from six European cities. METHODS: Seventy-two healthy subjects (age 20-70 years) were selected. At 30 min and 60 min after fluorescein injection, fluorescein mass in vitreous was calculated from the concentrations measured along the optical axis of the eye. Non-protein-bound fluorescein (NPBF) concentrations were measured in plasma prepared from blood samples taken 7, 15 and 55 min after injection. Blood-retinal barrier permeability (PBRB) was calculated from the vitreous fluorescein mass and the time integral of NPBF and was corrected for the autofluorescence of ocular tissue and for lenticular light transmittance. RESULTS: Mean PBRB values +/- SD (nm.s-1) were 2.07 +/- 0.54 (Coimbra), 2.01 +/- 0.43 (Frankfurt), 2.24 +/- 0.50 (Ghent), 2.37 +/- 0.56 (Herlev), 1.89 +/- 0.44 (Leiden) and 1.74 +/- 0.38 (Porto). Differences between centers were not significant (P > 0.35). Measurements were reproducible and independent of the time after fluorescein injection (P > 0.50). A PBRB higher than 3.16 nm.s-1 or a value which had increased by 32% was considered abnormal (P < 0.05). CONCLUSION: PBRB values were similar in all centers. The results demonstrate that this is a highly sensitive and reliable method for measuring the permeability of the blood-retinal barrier.

Adult↗

Evaluation of diabetic retinopathy by fluorophotometry. European concerted action on ocular fluorometry.

BACKGROUND: Fluorophotometric variables (permeability of the blood-retinal barrier (BRB) and blood-aqueous barrier (BAB), corneal autofluorescence, and lenticular light transmittance) are reported to correlate with the severity of diabetic retinopathy. This preliminary multicenter study was performed to measure these variables simultaneously in patients with type 2 diabetes mellitus and to assess which of these variables could be of help in evaluating diabetic retinopathy. METHODS: Eighty-two patients with type 2 diabetes and diabetic retinopathy were recruited in seven European university clinics. Each patient was investigated three times, at intervals of about one year. The investigations included fluorophotometric determination of corneal autofluorescence, lenticular light transmittance, and permeability of the BRB and BAB. Retinopathy was classified into four grades, using a simplified evaluation system based on the Modified Airlie House retinopathy classification and applied to color fundus slides of standard fields 1 and 2. RESULTS: Multiregression analyses revealed that only corneal autofluorescence and BRB permeability were correlated with the severity of diabetic retinopathy (P < 0.05). Corneal autofluorescence and BRB permeability as single variables were found to be indicative of severe nonproliferative retinopathy and proliferative retinopathy (sensitivity 100% and 86%, respectively, and specificity 65% and 85%, respectively). Combination of both variables increased specificity to 92%. CONCLUSIONS: This preliminary multicenter study shows that fluorophotometric variables can be measured simultaneously and reliably in patients with diabetes and that corneal autofluorescence and BRB permeability (individually or in combination) could be of help in detecting severe non-proliferative retinopathy and proliferative retinopathy.

Blood-Aqueous Barrier↗